{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Respimat", "query": { "intervention": "Placebo Respimat" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 50, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Respimat&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-03T00:01:58.748Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01397162", "title": "Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) Therapy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone propionate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "BI 54903", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "12 Years to 65 Years" }, "enrollment_count": 29, "start_date": "2011-07-21", "completion_date": "2011-12-23", "has_results": true, "last_update_posted_date": "2022-06-23", "last_synced_at": "2026-09-03T00:01:58.748Z", "location_count": 41, "location_summary": "Fountain Valley, California • Huntington Beach, California • Long Beach, California + 36 more", "locations": [ { "city": "Fountain Valley", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Palmdale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01397162" }, { "nct_id": "NCT01040728", "title": "A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Olodaterol (BI1744) Low", "type": "DRUG" }, { "name": "Olodaterol (BI1744) High", "type": "DRUG" }, { "name": "Tiotropium 18 mcg", "type": "DRUG" }, { "name": "Placebo (for Olodaterol (BI1744)l)", "type": "DRUG" }, { "name": "Placebo (for Tiotropium)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 122, "start_date": "2010-01", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-06-30", "last_synced_at": "2026-09-03T00:01:58.748Z", "location_count": 3, "location_summary": "Jasper, Alabama • Clearwater, Florida • Tampa, Florida", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01040728" }, { "nct_id": "NCT00932646", "title": "Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "BI 1744 (Olodaterol) Low Dose", "type": "DRUG" }, { "name": "BI 1744 (Olodaterol) Medium Dose", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Foradil", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 100, "start_date": "2009-06", "completion_date": null, "has_results": true, "last_update_posted_date": "2016-02-05", "last_synced_at": "2026-09-03T00:01:58.748Z", "location_count": 13, "location_summary": "Jasper, Alabama • Clearwater, Florida • DeLand, Florida + 10 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Clearwater", "state": "Florida" }, { "city": "DeLand", "state": "Florida" }, { "city": "Winter Park", "state": "Florida" }, { "city": "Austell", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00932646" }, { "nct_id": "NCT02006732", "title": "Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "olodaterol", "type": "DRUG" }, { "name": "tiotropium", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 809, "start_date": "2013-11", "completion_date": "2014-11", "has_results": true, "last_update_posted_date": "2016-01-20", "last_synced_at": "2026-09-03T00:01:58.748Z", "location_count": 20, "location_summary": "Jasper, Alabama • Stamford, Connecticut • Clearwater, Florida + 17 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Stamford", "state": "Connecticut" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Duluth", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02006732" }, { "nct_id": "NCT00387088", "title": "Tiotropium / Respimat One Year Study in COPD.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Respimat", "type": "DEVICE" }, { "name": "Tiotropium", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 3991, "start_date": "2006-09", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-05-16", "last_synced_at": "2026-09-03T00:01:58.748Z", "location_count": 57, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Berkeley, California + 48 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Berkeley", "state": "California" }, { "city": "Huntington Park", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00387088" }, { "nct_id": "NCT00772538", "title": "Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "tiotropium 5mcg/day", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 459, "start_date": "2008-10", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-08-18", "last_synced_at": "2026-09-03T00:01:58.748Z", "location_count": 20, "location_summary": "Birmingham, Alabama • Los Angeles, California • Riverside, California + 16 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00772538" }, { "nct_id": "NCT01172808", "title": "Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma I", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "tiotropium Respimat® low dose", "type": "DRUG" }, { "name": "tiotropium Respimat® high dose", "type": "DRUG" }, { "name": "50 mcg salmeterol HFA MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 1071, "start_date": "2010-08", "completion_date": "2012-11", "has_results": true, "last_update_posted_date": "2014-06-09", "last_synced_at": "2026-09-03T00:01:58.748Z", "location_count": 21, "location_summary": "Huntington Beach, California • Mission Viejo, California • San Diego, California + 17 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Wheat Ridge", "state": "Colorado" }, { "city": "Coeur d'Alene", "state": "Idaho" } ], "official_url": "https://clinicaltrials.gov/study/NCT01172808" }, { "nct_id": "NCT01172821", "title": "Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma II", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "placebo", "type": "DRUG" }, { "name": "tiotropium Respimat® low dose", "type": "DRUG" }, { "name": "tiotropium Respimat® high dose", "type": "DRUG" }, { "name": "50 mcg salmeterol HFA MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 1032, "start_date": "2010-08", "completion_date": "2012-11", "has_results": true, "last_update_posted_date": "2014-06-09", "last_synced_at": "2026-09-03T00:01:58.748Z", "location_count": 18, "location_summary": "Los Angeles, California • Stockton, California • Centennial, Colorado + 15 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Stockton", "state": "California" }, { "city": "Centennial", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" }, { "city": "Panama City", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01172821" }, { "nct_id": "NCT00782509", "title": "12 / 48 wk Pivotal PFT vs PBO in COPD II", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Olodaterol (BI 1744)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 644, "start_date": "2009-02", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-06-27", "last_synced_at": "2026-09-03T00:01:58.748Z", "location_count": 28, "location_summary": "Mobile, Alabama • Wheat Ridge, Colorado • Waterbury, Connecticut + 23 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Wheat Ridge", "state": "Colorado" }, { "city": "Wheat Ridge", "state": "Colorado" }, { "city": "Waterbury", "state": "Connecticut" }, { "city": "Clearwater", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00782509" }, { "nct_id": "NCT00240435", "title": "12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "5 mcg once daily tiotropium inhalation solution delivered by the Respimat inhaler", "type": "DEVICE" }, { "name": "10 mcg once daily tiotropium inhalation solution delivered by the Respimat inhaler", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 491, "start_date": "2002-11", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-11-01", "last_synced_at": "2026-09-03T00:01:58.748Z", "location_count": 14, "location_summary": "Birmingham, Alabama • Downey, California • Los Angeles, California + 11 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Downey", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Wheat Ridge", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00240435" } ] }